doi: 10.3389/fpls.2024.1373801 Received 20 January 2024 Accepted 23 February 2024 Published 12 March 2024 Volume 15 - 2024 Edited by Ahmed Abdelkhalek, City of Scientific Research and Technological Applications, Egypt Reviewed by Nuria Montes, Hospital Universitario de La Princesa, Spain Updates Copyright 2024 Kozie, Otulak-Kozie and Rusin
Don't Want Daily Injections Some patients simply don't want to inject themselves daily for weeks
Institutional biosafety committees approve KPV protocols faster because published human safety data exists
In research, KLOW is typically injected subcutaneously, rotating sites (abdomen, flank, thigh) to avoid repeated trauma at one spot
The patient profile that benefits most from combining both therapies fits what we call the anti-aging aesthetics track at Perfect B: GHK-Cu for tissue repair and hair, NAD+ for cellular energy and longevity